drupal statistics module

Jump to content


hair loss radio

Photo

ReplicelíS Update Shows Clinical Trial Is On Track

hair loss

  • Please log in to reply
No replies to this topic

#1 Bill

Bill

    Advanced Member

  • Admin
  • PipPipPip
  • 509 posts

Posted 03 February 2012 - 06:01 AM

Feb 2012

Posted Image


RepliCel Life Sciences, Inc. (REPCF) recently provided an update on its first-in-man clinical trial, TS001-2009, for a potentially revolutionary new treatment for hair loss in men and women. The highly anticipated results from the initial six-month post injection follow-up period are nearly collected.

Seventeen of the 19 subjects have had their six-month follow-up visit. During these visits, they had their overall health evaluated, including subjective and objective assessments of the verum and placebo injection sites.

Digital pictures were also taken of the scalp injection sites. The remaining two patients will complete their six-month follow-ups by the end of March, while four patients should finish their 12-month follow-ups by that same time.

The TS001-2009 study team will be doing thorough reviews of the data available throughout the months of March and April this year.

When completed, this will lead to the study being “un-blinded,” so that the analysis team can analyze the collected data. The patients will also continue to be monitored through 2013 for any changes in their overall health.

New Treatment With Great Potential

At the core of RepliCel’s revolutionary new technology is an innovative process that focuses on the regenerative properties of the dermal sheath cup cells which are found in hair follicles.

By extracting the cells from a patient’s healthy hair follicles–typically found in the lower area of the back of the scalp–and replicating them in a proprietary culture medium for several months, the company’s scientific team believes that by re-injecting these replicated cells back into balding areas on the patient’s scalp, they could potentially stimulate hair growth.

Complete hair loss article





0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users